Nikhil Meena

Professor

University of Arkansas for Medical Sciences

faculty

Internal Med, College of Medicine

17 h-index 126 pubs 862 cited

Research Areas

SARS-CoV-2 and COVID-19 Research Chronic Obstructive Pulmonary Disease (COPD) Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies Medical Imaging Techniques and Applications Meta-analysis and systematic reviews Emergency and Acute Care Studies

Links

ORCID Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Nikhil Meena's research focuses on critical care and pulmonary medicine, with a particular emphasis on respiratory illnesses and their management. He has investigated the use of robotic bronchoscopy for diagnosing peripheral pulmonary lesions and assessed the competency of fellows in electromagnetic navigation bronchoscopy. His work also addresses the pharmacological effects of treatments, such as the association of tocilizumab with increased fungal infections in critically ill COVID-19 patients with acute renal failure. Meena has explored advanced diagnostic techniques, including the yield of pulmonologist-performed EUS-B-FNA for subdiaphragmatic lesions and potential diagnostic pitfalls in lung carcinoid tumors. He also contributes to the understanding of sepsis trial methodologies, examining Bayesian approaches as a potential path forward. His scholarship metrics include an h-index of 17, with 126 total publications and 862 citations. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Rajani Jagana, Sarenthia M. Epps, Barrett J. Burger, and Susanne K. Jeffus, each with whom he shares four publications.

Metrics

  • h-index: 17
  • Publications: 126
  • Citations: 862

Selected Publications

  • American Association for Bronchology and Interventional Pulmonology (AABIP) Evidence-Based Guidelines on Bronchoscopic Diagnosis and Staging of Lung Cancer (2025) DOI
  • Delivering a Regional Procedural Bootcamp for Incoming Pulmonary and Critical Care Medicine Fellows (2025) DOI
  • Correction to: Bayesian methods: a potential path forward for sepsis trials (2024) DOI
  • Bayesian methods: a potential path forward for sepsis trials (2023) DOI
  • Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023) DOI
  • One- versus two-specimen Xpert strategy to discontinue airborne isolation in suspected pulmonary tuberculosis: systematic review and meta-analysis (2023) DOI
  • The yield and impact of pulmonologist-performed EUS-B-FNA of subdiaphragmatic lesions—an institutional experience (2023) DOI
  • Bronchocutaneous Fistula Without Pneumothorax: A Rare Complication of Tube Thoracostomy (2023) DOI
  • Case of Persistent Wheeze and Atelectasis in an Adolescent Male (2023) DOI
  • A 72-Year-Old Woman With Dyspnea, Multiple Pulmonary Nodules, and Mediastinal Lymphadenopathy (2022) DOI
  • Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience (2022) DOI
  • A Multicenter Study Assessing Interventional Pulmonary Fellow Competency in Electromagnetic Navigation Bronchoscopy (2022) DOI
  • A 34-Year-Old Man With Lightheadedness and Dyspnea (2022) DOI
  • 195: ZINC USE IS ASSOCIATED WITH IMPROVED OUTCOMES IN COVID-19: RESULTS FROM THE CRUSH-COVID REGISTRY (2021) DOI
  • 303: A PANDEMIC WITHIN AN EPIDEMIC: EVALUATION OF COVID-19 IN THE OBESE POPULATION (2021) DOI

Grants & Funding

  • A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319) Savara, Inc Principal Investigator
  • No FP attached GlaxoSmithKline - Pass Through: PPD Development, LP Principal Investigator
  • A Prospective, Multicenter, Randomized, Open-Label Study to Evaluate the Efficacy and Safety of PMX Cartridge in Addition to Standard Medical Care for Patients with Endotoxemic Septic Shock: TIGRIS TRIAL (IRB 262982) Spectral Medical, Inc Principal Investigator
  • A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP) (IRB 262319) Savara, Inc Principal Investigator
  • A Multicenter Platform Trial of Putative Therapeutics for the Treatment of COVID-19 in Hospitalized Adults (IRB 262510) NIH/Nat. Inst. of Allergy & Infectious Diseases - Pass Through: Leidos Principal Investigator
  • No FP attached Pharmerit International Principal Investigator
  • No FP attached Genentech, Inc. - Pass Through: PPD Development, LP Principal Investigator

Collaborators

Researchers in the database who share publications

Rajani Jagana University of Arkansas for Medical Sciences 4 shared publications Sarenthia M. Epps University of Arkansas for Medical Sciences 4 shared publications Barrett J. Burger University of Arkansas for Medical Sciences 4 shared publications Susanne K. Jeffus University of Arkansas for Medical Sciences 4 shared publications Anand N. Venkata University of Arkansas for Medical Sciences 3 shared publications William T. Atchley University of Arkansas for Medical Sciences 3 shared publications Jose Diego Caceres University of Arkansas for Medical Sciences 3 shared publications Siddharthan Vaithilingam University of Arkansas for Medical Sciences 2 shared publications

Similar Researchers

Based on overlapping research topics

Krishna Kakkera University of Arkansas for Medical Sciences
Chronic Obstructive Pulmonary Disease (COPD) Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Suryakala Buddha University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research Microbial infections and disease research Medical Imaging Techniques and Applications
Good match 4 shared topics
Rajani Jagana University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Sarenthia M. Epps University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Saloni Shirke University of Arkansas – Fort Smith
SARS-CoV-2 and COVID-19 Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Barrett J. Burger University of Arkansas for Medical Sciences
SARS-CoV-2 and COVID-19 Research Microbial infections and disease research Pharmacological Effects and Toxicity Studies
Good match 4 shared topics